October 2026 Update

Federal health data reveals a significant shift in the distribution of national HIV prevention resources. Following recent announcements regarding the restructuring of federal grants, the Centers for Disease Control and Prevention (CDC) released supplemental health department funding on September 3, 2026, totaling $91 million. This figure represents a 24% reduction from the anticipated $120 million originally described in preliminary award announcements.

While 30 health departments received the funding amounts they originally anticipated, 14 jurisdictions experienced funding reductions of 25% or more, with six of those seeing cuts exceeding 40%. To match prior funding levels previously sustained by direct community grants under the legacy PS21-2102 program, health departments would now need to allocate an average of 46% of their supplemental funding directly to community-based organizations (CBOs). However, the actual allocation requirements vary widely by department. Furthermore, five eligible health departments—Alaska, Arkansas, Idaho, Tennessee, and Wyoming—were not awarded any supplemental funding at all, leaving CBOs in Arkansas and Tennessee that previously relied on direct funding entirely without this new stream of state-channeled support.

This development follows earlier reports that the CDC decided against renewing its flagship, five-year HIV prevention grant program dedicated specifically to community-based organizations, known as grant number PS21-2102. For decades, CBOs have served on the front lines of the national HIV response. As outlined in the original grant announcements, these organizations have long been recognized for their accessibility, historical roots, and deep credibility within local populations, making them essential partners in delivering comprehensive, high-impact prevention services.

Grantees historically utilized these funds to conduct a diverse array of integrated prevention activities. These efforts included routine HIV and other sexually transmitted infection (STI) testing, active linkage-to-care initiatives, pre-exposure prophylaxis (PrEP) navigation, and comprehensive partner services, among numerous other community-level interventions.

Concurrently, the CDC made supplemental funding available to state and local health departments to execute HIV prevention activities under a separate, preexisting grant mechanism known as PS24-0047, which requires health departments to apply for consideration. Health departments receiving these supplemental grants are strongly encouraged—though not strictly required—to engage community-based partners. Higher suggested allocations are designated for organizations operating within jurisdictions prioritized by the federal "Ending the Epidemic" (EHE) initiative.

While these supplemental funds do not directly replace the direct-to-CBO funding structure of the dissolved PS21-2102 program, they represent the primary potential avenue for some organizations to secure future resources. Ultimately, individual health departments will determine their own allocation strategies, but this new structural approach threatens to destabilize the operational budgets and long-term viability of many community-based organizations, particularly smaller entities with fewer pre-existing financial reserves. More broadly, this shift marks a profound departure from how the CDC has historically structured its HIV prevention strategy, effectively terminating direct funding arrangements with CBOs that had been in place since the late 1980s.

Congressional Concerns and Federal Policy Shifts

Public health advocates and members of Congress have expressed deep concern regarding these sweeping changes, which reports indicate were implemented at the direction of the Office of Management and Budget (OMB). This transition coincides with broader questions regarding the federal government’s long-term commitment to domestic HIV prevention. The current administration has consistently sought to eliminate CDC funding for HIV prevention entirely, though those proposed cuts have repeatedly been rejected by Congress.

Additionally, the administration has pursued administrative actions aimed at limiting or terminating federal funding and programming for initiatives addressing LGBTQ+ health issues and racial and ethnic health disparities. According to available federal spending data, many of the CBOs funded under the previous grant structure specifically focused their prevention efforts on these marginalized populations, working diligently to ensure that critical resources reached Black, Latino, and transgender individuals—groups that continue to be disproportionately impacted by the HIV epidemic nationwide.

To evaluate the scope and potential impact of this structural transition, public health analysts utilized data from USAspending.gov, the federal government’s official repository for award and spending records. The analysis provides a comprehensive snapshot of where, to whom, and at what financial thresholds the historical CBO grants under PS21-2102 were distributed. Overall, the data indicates that community-based organizations stand to lose substantial amounts of dedicated funding moving forward, with more than $230 million in cumulative programming at stake. Furthermore, the analysis reveals that the largest concentration of these affected organizations is located in the American South, the geographic region that consistently records the highest number of new HIV diagnoses in the United States.

Findings and Regional Impact

The long-term operational outcome of this transition remains difficult to fully predict, as it is not yet known which specific health departments successfully applied for or will ultimately be awarded supplemental funds, nor what precise share of those funds health departments will choose to pass along to community groups. However, the analysis demonstrates that even if health departments decide to fund CBOs at the absolute minimum recommended levels, overall funding directed toward community organizations will experience severe contractions across numerous regions, with some areas facing catastrophic fiscal drops.

Faced with sharply diminished resources, grassroots organizations will likely find themselves significantly less equipped to deliver, maintain, or support vital HIV prevention programs. Public health experts warn that this localized erosion of services could weaken the broader national HIV response, ultimately increasing the vulnerability of high-risk communities to rising rates of new infections.

Methodology and Data Sources

The findings of the spending analysis were derived from multiple federal and institutional datasets. Funding totals for the legacy PS21-2102 grant program were extracted from USAspending.gov, capturing records through late July 2026. The examination covered the full five-year grant lifecycle spanning from 2021 through 2025, incorporating base year allocations alongside supplemental or revision amounts. Continuation funding provided for the 2026 fiscal year was also integrated, utilizing the state and county designations officially assigned within the federal spending database.

Estimates for the newer PS24-0047 supplemental funding levels were compiled directly from the CDC’s updated supplement guidance documentation associated with Notice of Funding Opportunity CDC-RFA-PS-24-0047. That federal announcement identified 60 state and local health departments as eligible applicants for the new supplemental pool. Among the 96 distinct organizations previously funded through the expiring PS21-2102 mechanism, all but two organizations—located in Tennessee—operated within those designated health department jurisdictions. In total, these direct-funded CBOs were based across 36 of the 60 eligible health department regions.

To assess how the estimated one-year PS24-0047 supplemental funding allocated to CBOs would compare historically to the final year of the PS21-2102 base funding, researchers evaluated CDC guidance encouraging grantees to dedicate a minimum of 10% of supplemental funding to support partnerships with CBOs, and a minimum of 25% for designated EHE jurisdictions. Because the CDC has historically delineated specific shares of health department funding explicitly dedicated to EHE activities versus non-EHE activities—and because that specific breakdown was not yet available for the new supplement—analysts applied blanket 10% and 25% allocation scenarios to the estimated supplemental award levels. This methodology established a realistic range of minimum anticipated funding for community partners. Because the PS24-0047 supplemental allocations are structured as one-year awards, the comparative analysis utilized exclusively the final year baseline figures from the 2025 fiscal year of the original CBO grants.